MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea · Delayed Price · Currency is KRW 1,300.00
-99.00 (-7.08%)
At close: Oct 23, 2026
MEDIZEN HUMANCARE Market Cap
MEDIZEN HUMANCARE has a market cap or net worth of 3 billion as of October 23, 2026. It is the 47,611th most valuable company in the world and the 2,722nd biggest in South Korea. Its market cap has decreased by 31.58% in one year.
Market Cap
3.00B
Enterprise Value
n/a
Revenue
583.88M
Global Rank
Country Rank
#2,722 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, MEDIZEN HUMANCARE's market cap has decreased from 20.81B to 3.00B, a decrease of -85.60%. That is a compound annual growth rate of -18.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.00B | -23.53% |
| Dec 30, 2025 | 3.92B | -46.03% |
| Dec 30, 2024 | 7.26B | -21.25% |
| Dec 28, 2023 | 9.22B | -33.88% |
| Dec 29, 2022 | 13.94B | -13.57% |
| Dec 30, 2021 | 16.13B | -15.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 315.98B |
| HLB bioStep | 112.35B |
| DreamCIS | 102.46B |
| P&K Skin Research Center | 49.10B |
| Kolmar BioTech | 34.84B |
| DT&CRO CO. | 27.42B |
| SLS BIO | 26.89B |
| C&R Research | 25.80B |